Isatuximab and Pd: A Real-Life Look in Japan
In Japan, doctors kept an eye on how well isatuximab plus pomalidomide and dexamethasone (Isa-Pd) worked for people with relapsed or refractory multiple myeloma (RRMM) who were frail. They collected data from patients treated between October 2020 and October 2021, following them for up to a year. Ou